Efficacy and safety of low‐dose digoxin in patients with heart failure. Rationale and design of the DECISION trial

Aims Digoxin is the oldest drug in cardiovascular (CV) medicine, and one trial conducted >25 years ago showed a reduction in heart failure (HF) hospitalizations but no effect on mortality. However, later studies suggested that the dose of digoxin used in that trial (and other studies) may have be...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of heart failure 2024-10, Vol.26 (10), p.2223-2230
Hauptverfasser: Veldhuisen, Dirk J., Rienstra, Michiel, Mosterd, Arend, Alings, A. Marco, Asselt, Antoinette D.J., Bouvy, Marcel L, Tijssen, Jan G.P., Schaap, Jeroen, Wall, Ernst E., Voors, Adriaan A., Boorsma, Eva M., Lok, Dirk J.A., Crijns, Harry J.G.M., Schut, Astrid, Vijver, Marlene A.T., Voordes, Geert H.D., Vos, Agaath H., Maas‐Soer, Ester L., Smit, Nicoline W., Touw, Daan J., Samuel, Michelle, Meer, Peter, Alings, Marco, Tijssen, Jan, Asselt, Thea, Bouvy, Marcel, Crijns, Harry J. G. M., Gaillard, Carlo, Veeger, Nick
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!